We are live on
!
Find out more
SAM
Strategy Asset Managers Portfolio holdings
AUM
$650M
Turnover
21.36%
1-Year Est. Return
25.51%
This Fund
S&P 500
This Quarter
Est. Return
+6.85%
1 Year Est. Return
+25.51%
3 Year Est. Return
+115.5%
5 Year Est. Return
+130.94%
10 Year Est. Return
+375.79%
AUM
$440M
AUM Growth
+$22.9M
(+5.5%)
Cap. Flow
-$2M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
26.85%
Holding
137
New
5
Increased
63
Reduced
45
Closed
2
Avg Time Held
1.6
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.79M |
| 2 |
Diageo
DEO
|
+$387K |
| 3 |
General Dynamics
GD
|
+$337K |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$238K |
| 5 |
AT&T
T
|
+$235K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$396K |
| 2 |
Walt Disney
DIS
|
+$395K |
| 3 |
Microsoft
MSFT
|
+$365K |
| 4 |
Targa Resources
TRGP
|
+$334K |
| 5 |
Anywhere Real Estate
HOUS
|
+$319K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.91% |
| 2 | Technology | 14.54% |
| 3 | Industrials | 12.69% |
| 4 | Consumer Staples | 12.11% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
CVS Health
CVS
$119B
| $14.8M | 3.37% |
151,681
-1,614
| -1% | -$158K |
2013 Q2
10 quarters
|
|
|
2
Microsoft
MSFT
$3.99T
| $13.1M | 2.99% |
236,957
-6,945
| -3% | -$365K |
2013 Q2
10 quarters
|
|
3
Lockheed Martin
LMT
$126B
| $12.3M | 2.79% |
56,557
-1,170
| -2% | -$254K |
2013 Q2
10 quarters
|
|
|
4
Bristol-Myers Squibb
BMY
$124B
| $12.3M | 2.79% |
178,216
-5,988
| -3% | -$396K |
2013 Q2
10 quarters
|
|
5
DuPont de Nemours
DD
$17.9B
| $11.1M | 2.51% |
84,772
-1,341
| -2% | -$172K |
2013 Q4
8 quarters
|
|
|
6
Walt Disney
DIS
$193B
| $11M | 2.51% |
104,811
-3,548
| -3% | -$395K |
2013 Q2
10 quarters
|
|
7
American International
AIG
$41.9B
| $11M | 2.5% |
177,475
-4,109
| -2% | -$251K |
2014 Q1
7 quarters
|
|
8
Altria Group
MO
$125B
| $10.9M | 2.48% |
187,100
-3,003
| -2% | -$174K |
2013 Q2
10 quarters
|
|
9
Teva Pharmaceutical Industries Limited
TEVA
$48.2B
| $10.8M | 2.46% |
164,542
-4,702
| -3% | -$291K |
2013 Q2
10 quarters
|
|
10
JPMorgan Chase
JPM
$911B
| $10.8M | 2.45% |
162,903
-4,038
| -2% | -$263K |
2013 Q2
10 quarters
|
|
11
Johnson & Johnson
JNJ
$617B
| $10.8M | 2.45% |
104,678
-1,199
| -1% | -$121K |
2013 Q2
10 quarters
|
|
12
Honeywell
HON
$67.2B
| $10.6M | 2.4% |
113,371
-2,490
| -2% | -$228K |
2013 Q2
10 quarters
|
|
13
Cisco
CSCO
$429B
| $9.61M | 2.19% |
353,905
-3,506
| -1% | -$96.7K |
2013 Q2
10 quarters
|
|
14
Merck
MRK
$361B
| $9.32M | 2.12% |
184,834
-6,230
| -3% | -$314K |
2013 Q2
10 quarters
|
|
15
Procter & Gamble
PG
$369B
| $9.16M | 2.08% |
115,305
-3,240
| -3% | -$248K |
2013 Q2
10 quarters
|
|
16
United Parcel Service
UPS
$84.5B
| $8.64M | 1.96% |
89,739
-1,026
| -1% | -$105K |
2013 Q4
8 quarters
|
|
17
Oracle
ORCL
$400B
| $8.54M | 1.94% |
233,648
-7,679
| -3% | -$293K |
2013 Q2
10 quarters
|
|
|
BHI
18
DELISTED
Baker Hughes
BHI
| $8.5M | 1.93% |
184,249
-1,357
| -0.7% | -$69.5K |
2013 Q2
10 quarters
|
|
19
Ford
F
$50.6B
| $8.41M | 1.91% |
597,070
-11,227
| -2% | -$163K |
2013 Q4
8 quarters
|
|
|
20
Diageo
DEO
$52.6B
| $8.4M | 1.91% |
76,994
+3,432
| +5% | +$387K |
2015 Q3
1 quarter
|
|
21
DELISTED
EMC CORPORATION
EMC
| $8.34M | 1.9% |
324,805
-11,089
| -3% | -$288K |
2013 Q2
10 quarters
|
|
22
Loews
L
$22.4B
| $8.22M | 1.87% |
213,997
-2,478
| -1% | -$92.3K |
2013 Q2
10 quarters
|
|
|
23
DELISTED
Anywhere Real Estate
HOUS
| $6.84M | 1.56% |
186,583
-8,065
| -4% | -$319K |
2013 Q2
10 quarters
|
|
|
RDS.A
24
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $6.49M | 1.48% |
149,597
-4,474
| -3% | -$213K |
2013 Q2
10 quarters
|
|
25
Fluor
FLR
$6.46B
| $6.21M | 1.41% |
131,418
-2,542
| -2% | -$120K |
2013 Q2
10 quarters
|
|
Similar funds
BI
GCM
GWAG
BRIM
PPW
OCAM
AAS
TAWM
Strategy Asset Managers's Q4 2015 Portfolio in Review
As of Q4 2015, Strategy Asset Managers held 137 positions worth $440M, up 5.5% from $417M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Strategy Asset Managers's Q4 2015 filing shows 5 new, 63 increased, 45 reduced and 2 closed positions. Its largest new stake was General Dynamics: 2,358 shares worth $324K. The largest sale was Bristol-Myers Squibb, an estimated $396K.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Strategy Asset Managers's largest Q4 2015 buy was General Dynamics: 2,358 shares worth $324K.
- Strategy Asset Managers added most to State Street SPDR S&P 500 ETF Trust in Q4 2015, an estimated $1.79M increase.
- Strategy Asset Managers's biggest Q4 2015 reduction was Bristol-Myers Squibb, cutting an estimated $396K.
- Strategy Asset Managers fully exited Targa Resources in Q4 2015, selling an estimated $334K.
- Strategy Asset Managers's ten largest holdings make up 27% of its $440M portfolio in Q4 2015.
- Strategy Asset Managers opened 5 new positions and closed 2 in Q4 2015.
- Strategy Asset Managers's portfolio value rose 5.5% quarter-over-quarter to $440M.
Based on Strategy Asset Managers's 13F filing for Q4 2015, filed 29 Jan 2016.